News

The Manila Times1d
Artelo's Fatty Acid Binding Protein 5 Inhibitor, ART26.12, Compares Favorably to Naproxen in an Osteoarthritis Pain Study
Positive effects of ART26.12 were observed in a surgical rat model of osteoarthritis, in which either single or repeated oral ...
American Council on Science and Health14d
Do Omega-6 Fats Fuel Aggressive Breast Cancer? What the Latest Study Shows
By now, you’ve probably heard that seed oils are the nutritional villain du jour. A recent study takes a more measured, ...
New Independent Review Paper Strengthens Therapeutic Rationale for Artelo’s FABP Inhibitor Program in Anxiety and Depression
Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, ...
Morningstar4d
New Independent Review Paper Strengthens Therapeutic Rationale for Artelo’s FABP Inhibitor Program in Anxiety and Depression
“We believe this paper provides compelling evidence that inhibition of FABP5 can significantly elevate anandamide levels, modulate stress-related neurocircuits, and produce robust anxiety ...
Artelo Biosciences Provides Business Update and Reports First Quarter 2025 Financial Results
Several Key Clinical Readouts in Addition to New Study Initiations Expected in 2025SOLANA BEACH, Caif., May 13, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage ...